OpenAlex
PricingAboutJobs
Log inGet started
Work

Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

HTML

Year: 2015
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-15-1354
Authors: Masafumi Ikeda, Takuji Okusaka, Shuichi Mitsunaga, Hideki Ueno, Toshiyuki Tamai, Takuya Suzuki, Seiichi Hayato, Tadashi Kadowaki, Kiwamu Okita, Hiromitsu Kumada
Institutions: National Cancer Center Hospital East, National Cancer Centre Japan, Eisai (Japan), Toranomon Hospital
Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: lenvatinib, hepatocellular carcinoma, maximum tolerated dose, dose-limiting toxicity, pharmacokinetics, pharmacodynamics, proteinuria, hepatic encephalopathy, hyperbilirubinemia, hypertension, c-kit-positive cells, endothelial cells, interleukin-6, vascular endothelial growth factor, granulocyte colony-stimulating factor, Child-Pugh score, tyrosine kinase inhibitors, antitumor efficacy
SDG: Good health and well-being

Open Access status: closed

Funder: Eisai
OpenAlex ID: W1834228192
FWCI: 5.666
Cites: 36
Cited by: 193
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms